
Kevin M. Picardat
Examiner (ID: 9381, Phone: (571)272-1841 , Office: P/2822 )
| Most Active Art Unit | 2822 |
| Art Unit(s) | 2813, 2825, 1104, 2899, 2822, 1763, 1732 |
| Total Applications | 2640 |
| Issued Applications | 2463 |
| Pending Applications | 47 |
| Abandoned Applications | 134 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7475300
[patent_doc_number] => 20040097709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Method for the preparation of a non-woven silk fibroin fabrics'
[patent_app_type] => new
[patent_app_number] => 10/398252
[patent_app_country] => US
[patent_app_date] => 2003-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3408
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097709.pdf
[firstpage_image] =>[orig_patent_app_number] => 10398252
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/398252 | Method for the preparation of a non-woven silk fibroin fabrics | Sep 27, 2001 | Issued |
Array
(
[id] => 1157827
[patent_doc_number] => 06762280
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-13
[patent_title] => 'High throughput assays for the proteotytic activities of clostridial neurotoxins'
[patent_app_type] => B2
[patent_app_number] => 09/962360
[patent_app_country] => US
[patent_app_date] => 2001-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8536
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/762/06762280.pdf
[firstpage_image] =>[orig_patent_app_number] => 09962360
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/962360 | High throughput assays for the proteotytic activities of clostridial neurotoxins | Sep 24, 2001 | Issued |
Array
(
[id] => 7367269
[patent_doc_number] => 20040006023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Antitumor theraphy comprising distamycin derivatives'
[patent_app_type] => new
[patent_app_number] => 10/381272
[patent_app_country] => US
[patent_app_date] => 2003-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1516
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20040006023.pdf
[firstpage_image] =>[orig_patent_app_number] => 10381272
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/381272 | Antitumor therapy comprising distamycin derivatives | Sep 20, 2001 | Issued |
Array
(
[id] => 1297944
[patent_doc_number] => 06623742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-23
[patent_title] => 'Methods for treating fibromyalgia'
[patent_app_type] => B2
[patent_app_number] => 09/954610
[patent_app_country] => US
[patent_app_date] => 2001-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9993
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/623/06623742.pdf
[firstpage_image] =>[orig_patent_app_number] => 09954610
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/954610 | Methods for treating fibromyalgia | Sep 16, 2001 | Issued |
Array
(
[id] => 6358520
[patent_doc_number] => 20020058303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Enhanced in vitro synthesis of active proteins containing disulfide bonds'
[patent_app_type] => new
[patent_app_number] => 09/948052
[patent_app_country] => US
[patent_app_date] => 2001-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7502
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058303.pdf
[firstpage_image] =>[orig_patent_app_number] => 09948052
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/948052 | Enhanced in vitro synthesis of active proteins containing disulfide bonds | Sep 4, 2001 | Issued |
Array
(
[id] => 5789427
[patent_doc_number] => 20020161176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Formation and anion-exchange of crystalline echinocandin ammonium salts'
[patent_app_type] => new
[patent_app_number] => 09/944309
[patent_app_country] => US
[patent_app_date] => 2001-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5597
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20020161176.pdf
[firstpage_image] =>[orig_patent_app_number] => 09944309
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/944309 | Formation and anion-exchange of crystalline echinocandin ammonium salts | Aug 29, 2001 | Issued |
Array
(
[id] => 6274654
[patent_doc_number] => 20020106356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Secreted proteins'
[patent_app_type] => new
[patent_app_number] => 09/941437
[patent_app_country] => US
[patent_app_date] => 2001-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14053
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20020106356.pdf
[firstpage_image] =>[orig_patent_app_number] => 09941437
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/941437 | Secreted proteins | Aug 27, 2001 | Abandoned |
Array
(
[id] => 6438680
[patent_doc_number] => 20020128191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Methods of treating conditions associated with corneal injury'
[patent_app_type] => new
[patent_app_number] => 09/941198
[patent_app_country] => US
[patent_app_date] => 2001-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9159
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128191.pdf
[firstpage_image] =>[orig_patent_app_number] => 09941198
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/941198 | Methods of treating conditions associated with corneal injury | Aug 26, 2001 | Abandoned |
Array
(
[id] => 710444
[patent_doc_number] => 07056729
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-06
[patent_title] => 'Botulinum neurotoxin-substance P conjugate or fusion protein for treating pain'
[patent_app_type] => utility
[patent_app_number] => 09/938112
[patent_app_country] => US
[patent_app_date] => 2001-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13111
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/056/07056729.pdf
[firstpage_image] =>[orig_patent_app_number] => 09938112
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/938112 | Botulinum neurotoxin-substance P conjugate or fusion protein for treating pain | Aug 22, 2001 | Issued |
Array
(
[id] => 236194
[patent_doc_number] => 07595175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-29
[patent_title] => 'Polyketides and their synthesis'
[patent_app_type] => utility
[patent_app_number] => 10/344738
[patent_app_country] => US
[patent_app_date] => 2001-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 11206
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/595/07595175.pdf
[firstpage_image] =>[orig_patent_app_number] => 10344738
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/344738 | Polyketides and their synthesis | Aug 13, 2001 | Issued |
| 09/913351 | Pharmacologically active polypeptide glycoconjugates | Aug 12, 2001 | Abandoned |
| 09/830556 | Method for the expression of recombinant proteins making use of the effect of stress and stress response mechanisms in the presence of compatible solutes | Aug 6, 2001 | Abandoned |
Array
(
[id] => 6407801
[patent_doc_number] => 20020037833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Clostridial toxin derivatives and methods for treating pain'
[patent_app_type] => new
[patent_app_number] => 09/922093
[patent_app_country] => US
[patent_app_date] => 2001-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14383
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20020037833.pdf
[firstpage_image] =>[orig_patent_app_number] => 09922093
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/922093 | Clostridial toxin derivatives and methods for treating pain | Aug 2, 2001 | Issued |
Array
(
[id] => 6000847
[patent_doc_number] => 20020028916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-07
[patent_title] => 'Purification process'
[patent_app_type] => new
[patent_app_number] => 09/920497
[patent_app_country] => US
[patent_app_date] => 2001-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3827
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20020028916.pdf
[firstpage_image] =>[orig_patent_app_number] => 09920497
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/920497 | Purification process | Jul 31, 2001 | Issued |
Array
(
[id] => 5936571
[patent_doc_number] => 20020061842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Method for sterilizing a native collagen in liquid medium, sterile native collagen obtained, compositions containing it and uses'
[patent_app_type] => new
[patent_app_number] => 09/917233
[patent_app_country] => US
[patent_app_date] => 2001-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12346
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061842.pdf
[firstpage_image] =>[orig_patent_app_number] => 09917233
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/917233 | Method for sterilizing a native collagen in liquid medium, sterile native collagen obtained, compositions containing it and uses | Jul 29, 2001 | Abandoned |
Array
(
[id] => 6243448
[patent_doc_number] => 20020045735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Method for extraction and purification of cartilage type proteoglycan'
[patent_app_type] => new
[patent_app_number] => 09/916250
[patent_app_country] => US
[patent_app_date] => 2001-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2901
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045735.pdf
[firstpage_image] =>[orig_patent_app_number] => 09916250
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/916250 | Method for extraction and purification of cartilage type proteoglycan | Jul 29, 2001 | Issued |
Array
(
[id] => 790603
[patent_doc_number] => 06984624
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-01-10
[patent_title] => 'Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/333554
[patent_app_country] => US
[patent_app_date] => 2001-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3687
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/984/06984624.pdf
[firstpage_image] =>[orig_patent_app_number] => 10333554
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/333554 | Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof | Jul 26, 2001 | Issued |
Array
(
[id] => 1253502
[patent_doc_number] => 06670326
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-30
[patent_title] => 'Depsipeptide compound'
[patent_app_type] => B1
[patent_app_number] => 09/889303
[patent_app_country] => US
[patent_app_date] => 2001-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5067
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/670/06670326.pdf
[firstpage_image] =>[orig_patent_app_number] => 09889303
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/889303 | Depsipeptide compound | Jul 12, 2001 | Issued |
Array
(
[id] => 6261789
[patent_doc_number] => 20020187938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Ghrelin antagonists'
[patent_app_type] => new
[patent_app_number] => 09/902556
[patent_app_country] => US
[patent_app_date] => 2001-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 782
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20020187938.pdf
[firstpage_image] =>[orig_patent_app_number] => 09902556
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/902556 | Ghrelin antagonists | Jul 9, 2001 | Abandoned |
| 09/869916 | Antitumor agents | Jul 8, 2001 | Abandoned |